Cite
Crafa A, Cannarella R, Condorelli RA, et al. Corrigendum to: Influence of 25‑hydroxy-cholecalciferol levels on SARS-CoV-2 infection and COVID-19 severity: A systematic review and meta-analysis [EClinicalMedicine 37 (2021) 100,967]. EClinicalMedicine. 2021;41:101168doi: 10.1016/j.eclinm.2021.101168.
Crafa, A., Cannarella, R., Condorelli, R. A., Mongioì, L. M., Barbagallo, F., Aversa, A., La Vignera, S., & Calogero, A. E. (2021). Corrigendum to: Influence of 25‑hydroxy-cholecalciferol levels on SARS-CoV-2 infection and COVID-19 severity: A systematic review and meta-analysis [EClinicalMedicine 37 (2021) 100,967]. EClinicalMedicine, 41101168. https://doi.org/10.1016/j.eclinm.2021.101168
Crafa, Andrea, et al. "Corrigendum to: Influence of 25‑hydroxy-cholecalciferol levels on SARS-CoV-2 infection and COVID-19 severity: A systematic review and meta-analysis [EClinicalMedicine 37 (2021) 100,967]." EClinicalMedicine vol. 41 (2021): 101168. doi: https://doi.org/10.1016/j.eclinm.2021.101168
Crafa A, Cannarella R, Condorelli RA, Mongioì LM, Barbagallo F, Aversa A, La Vignera S, Calogero AE. Corrigendum to: Influence of 25‑hydroxy-cholecalciferol levels on SARS-CoV-2 infection and COVID-19 severity: A systematic review and meta-analysis [EClinicalMedicine 37 (2021) 100,967]. EClinicalMedicine. 2021 Nov;41:101168. doi: 10.1016/j.eclinm.2021.101168. Epub 2021 Oct 20. PMID: 34693235; PMCID: PMC8527185.
Copy
Download .nbib